0001225208-24-005332.txt : 20240429 0001225208-24-005332.hdr.sgml : 20240429 20240429170602 ACCESSION NUMBER: 0001225208-24-005332 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240425 FILED AS OF DATE: 20240429 DATE AS OF CHANGE: 20240429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MULCAHY ANNE M CENTRAL INDEX KEY: 0001201725 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 24892436 MAIL ADDRESS: STREET 1: C/O GRAHAM HOLDINGS 1300 NORTH 17TH ST STREET 2: SUITE 1700 CITY: ARLINGTON STATE: VA ZIP: 22209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1229 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 4 1 doc4.xml X0508 4 2024-04-25 0000200406 JOHNSON & JOHNSON JNJ 0001201725 MULCAHY ANNE M ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 1 0 Deferred Share Units 2024-04-25 4 A 0 1385.6970 0.0000 A Common Stock 1385.6970 21470.6180 D Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person. /s/ Raavi K. Deol, as attorney-in-fact for Anne M. Mulcahy 2024-04-29